|
Rick...So I'll take that as "sell something else"...Actually, I was re-reading their prospectus and found besides the Herpes/Cytomegalovirus/Rhinovirus/Hep C, etc., etc. research, they are working on the VEGF Receptor- which I believe is in the now popular( read: hot) area of angiogenesis...I am looking closely at areas that appear "neglected", e.g., the "gene therapy" and "neuroscience" companies...In particular, I am reading up on Ariad, CoCenesys, Sibia, Avigen, Cortex and Synaptic...I own several and am considering adding to some positions...I appreciate your time in thoughtfully responding to my questions... |
